Glimitoss M 2mg/500mg Tablet SR
Manufacturer
Minitoss Medicines
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Key Information
Short Description
Glimitoss M 2mg/500mg Tablet SR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Dosage Form
Tablet SR
Introduction
Glimitoss M 2mg/500mg Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimitoss M 2mg/500mg Tablet SR is to be taken with food.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Glimitoss M 2mg/500mg Tablet SR.
Breastfeeding Warning
Glimitoss M 2mg/500mg Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Glimitoss M 2mg/500mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Glimitoss M 2mg/500mg Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Quick Tips
You should continue to exercise regularly eat a healthy diet and take your other diabetes medicines along with Glimitoss M 2mg/500mg Tablet SR. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Glimitoss M 2mg/500mg Tablet SR may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.
Related Medicines
Isryl-M2 Tablet
Mepride MF 2 Tablet SR
Glylim Forte Tablet SR
Diaset M2 SR Tablet
Metraff-G2 Tablet SR
Zyvana M2 Tablet SR
Varnglim 2mg/500mg Tablet SR
Metjet-MG2 Tablet SR
Glimin 2 MSR Tablet
Glimlen M 2mg/500mg Tablet SR
Frequently asked questions
What are the recommended storage conditions for Glimitoss M 2mg/500mg Tablet SR?
Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of unused medication. Ensure it is not consumed by pets, children, and other people.
Can the use of Glimitoss M 2mg/500mg Tablet SR lead to lactic acidosis?
Yes, the use of Glimitoss M 2mg/500mg Tablet SR can lead to lactic acidosis. It is a medical emergency caused by an increase in lactic acid levels in the blood. It is also known as MALA (Metformin-associated Lactic Acidosis). It is a rare side effect associated with metformin, and therefore, it is considered harmful for patients with underlying kidney disease, older adults, or those who take large amounts of alcohol. Symptoms of lactic acidosis may include muscle pain or weakness, dizziness, fatigue, feelings of coldness in arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or a slow heart rate. If you experience these symptoms, stop taking Glimitoss M 2mg/500mg Tablet SR immediately and contact your doctor.
What is Glimitoss M 2mg/500mg Tablet SR?
Glimitoss M 2mg/500mg Tablet SR is a combination of two medicines: Glimepiride and Metformin. This medicine is used for the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by lowering glucose production in the liver and improving insulin sensitivity. This combination is not recommended for treating type 1 DM.
What are the possible side effects of Glimitoss M 2mg/500mg Tablet SR?
Common side effects of Glimitoss M 2mg/500mg Tablet SR include hypoglycemia (low blood sugar level), altered taste, nausea, stomach pain, diarrhea, and headache. It can also lead to serious but rare side effects like lactic acidosis. On long-term use, it may cause vitamin B12 deficiency.
Can the use of Glimitoss M 2mg/500mg Tablet SR cause Vitamin B12 deficiency?
Yes, long-term use of Glimitoss M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency. It interferes with vitamin B12 absorption in the stomach. Untreated, it may result in anemia and nerve problems. Patients may experience tingling sensations in their hands and feet, weakness, urinary issues, changes in mental status, and difficulty maintaining balance (ataxia). To prevent these problems, some researchers recommend supplementing with vitamin B12 from external sources at least once a year.
Can the use of Glimitoss M 2mg/500mg Tablet SR lead to hypoglycemia?
Yes, the use of Glimitoss M 2mg/500mg Tablet SR can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely to occur if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications concurrently.
Is it safe to take alcohol while I am also taking Glimitoss M 2mg/500mg Tablet SR?
No, it is not safe to combine Glimitoss M 2mg/500mg Tablet SR with alcohol. It may lower your blood sugar level and increase the risk of hypoglycemia. It can also raise lactic acidosis susceptibility.
